Cite

HARVARD Citation

    Atkins, M. et al. (2015). Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online]. 
  
Back to record